177 related articles for article (PubMed ID: 27162585)
1. Transition of Immunohistochemical Expression of E-Cadherin and Vimentin from Premalignant to Malignant Lesions of Oral Cavity and Oropharynx.
Akhtar K; Ara A; Siddiqui SA; Sherwani RK
Oman Med J; 2016 May; 31(3):165-9. PubMed ID: 27162585
[TBL] [Abstract][Full Text] [Related]
2. Role of Vimentin and E-cadherin Expression in Premalignant and Malignant Lesions of Oral Cavity.
Gupta SK; Agarwal S; Singh SN; Sehra R; Jat PS; Singhal P
Indian J Otolaryngol Head Neck Surg; 2022 Sep; 74(3):350-355. PubMed ID: 36213468
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of e-cadherin and vimentin expression for different grades of oral epithelial dysplasia and oral squamous cell carcinoma - An immunohistochemical study.
Puneeta N; Santosh T; Mishra I; Gaikwad P; Sahu A
J Oral Maxillofac Pathol; 2022; 26(2):285-286. PubMed ID: 35968190
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin Expression in Premalignant Lesions, Premalignant Conditions, Oral Squamous Cell Carcinoma, and Normal Mucosa: An Immunohistochemical Study.
Kalaimani G; Rao UDK; Joshua E; Ranganathan K
Cureus; 2023 Aug; 15(8):e44266. PubMed ID: 37772225
[TBL] [Abstract][Full Text] [Related]
5. The immunohistochemical investigations of cadherin "switch" during epithelial-mesenchymal transition of tongue squamous cell carcinoma.
Afrem MC; Mărgăritescu C; Crăiţoiu MM; Ciucă M; Şarlă CG; Cotoi OS
Rom J Morphol Embryol; 2014; 55(3 Suppl):1049-56. PubMed ID: 25607384
[TBL] [Abstract][Full Text] [Related]
6. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.
Chaw SY; Abdul Majeed A; Dalley AJ; Chan A; Stein S; Farah CS
Oral Oncol; 2012 Oct; 48(10):997-1006. PubMed ID: 22704062
[TBL] [Abstract][Full Text] [Related]
7. Expression of E-cadherin and vimentin in oral squamous cell carcinoma.
Zhou J; Tao D; Xu Q; Gao Z; Tang D
Int J Clin Exp Pathol; 2015; 8(3):3150-4. PubMed ID: 26045832
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis.
Nitta T; Sugihara K; Tsuyama S; Murata F
Cancer; 2000 Jan; 88(2):245-54. PubMed ID: 10640953
[TBL] [Abstract][Full Text] [Related]
9. Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.
Costa LC; Leite CF; Cardoso SV; Loyola AM; Faria PR; Souza PE; Horta MC
J Appl Oral Sci; 2015; 23(2):169-78. PubMed ID: 26018309
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of aberrant vimentin expression in oral premalignant lesions and carcinomas.
Sawant SS; Vaidya Mm; Chaukar DA; Alam H; Dmello C; Gangadaran P; Kannan S; Kane S; Dange PP; Dey N; Ranganathan K; D'Cruz AK
Oral Dis; 2014 Jul; 20(5):453-65. PubMed ID: 23865921
[TBL] [Abstract][Full Text] [Related]
12. Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas.
Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Uchida K; Kadosawa T; Taniyama H
Vet Pathol; 2017 Sep; 54(5):783-791. PubMed ID: 28494700
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma.
Santos-García A; Abad-Hernández MM; Fonseca-Sánchez E; Julián-González R; Galindo-Villardón P; Cruz-Hernández JJ; Bullón-Sopelana A
Med Oral Patol Oral Cir Bucal; 2006 Mar; 11(2):E100-5. PubMed ID: 16505783
[TBL] [Abstract][Full Text] [Related]
14. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
15. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias.
Bortoluzzi MC; Yurgel LS; Dekker NP; Jordan RC; Regezi JA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Dec; 98(6):698-704. PubMed ID: 15583543
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of vimentin predisposes oral premalignant lesion derived cells towards transformation.
Dmello C; Sawant S; Chaudhari PR; Dongre H; Ahire C; D'Souza ZC; Charles SE; Rane P; Costea DE; Chaukar D; Kane S; Vaidya M
Exp Mol Pathol; 2018 Dec; 105(3):243-251. PubMed ID: 30189187
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of epithelial-mesenchymal transition-related markers between cancer tissue and tumor emboli].
He N; Wu GF; Zhao HY; Han HX
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):758-61. PubMed ID: 22336160
[TBL] [Abstract][Full Text] [Related]
18. A bird's-eye view of pathologist over diagnostic confusion of oral cavity lesions.
Kalavathi LC; Chaitanya KV; Venkata VB
J Oral Maxillofac Pathol; 2023; 27(2):266-274. PubMed ID: 37854899
[TBL] [Abstract][Full Text] [Related]
19. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer.
Rashed HE; Hussein S; Mosaad H; Abdelwahab MM; Abdelhamid MI; Mohamed SY; Mohamed AM; Fayed A
Cancer Biomark; 2017 Jul; 20(1):107-122. PubMed ID: 28759954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
